Proteomics: A New Discipline in Cancer

Leading causes of cancer deaths include lack of early-detection systems and undiscovered biomarkers. Alongside recent promising genetic advances, we are encountering a discipline that may greatly facilitate early diagnosis: “Proteomics”
Proteomics studies proteins and their relationships
DNA is the cell's main controller. Each section is called a gene , and genetic information enables production of proteins carrying out vital bodily processes.
For a concrete example, imagine proteins as a meal: genes provide the recipe for producing them.
Protein research has increased recently. Our body has 22 thousand genes corresponding to more than 500.000protein types. Proteins are more complex than genes. Their modifications, relationships with different pathways, functions at different locations and responses to diseases or stimuli make them vitally important. High gene activity also does not necessarily mean abundant production of its protein. Cancer can therefore be considered a proteomic disease.
Besides genomic contributions, errors in protein modifications after production play an important role in cancer. Detecting tumor-specific proteins therefore offers great hope for early diagnosis.
The discipline examining proteins' cancer roles is called clinical proteomics is the name of this scientific discipline. The aim of clinical proteomics is to identify the proteins involved in cancer development and reveal the pathways in which they participate. To this end, researchers are studying the following topics;
- In cancer, drug resistanceand discovering the proteins causing it
- Cancer-causing rare proteins detected from small blood or urine samples
- Tumor dormancyand identifying its proteins to determine when and how tumors enter dormancy
- Identifying when and how mutated cancer proteins are damaged, to develop targeted treatments as therapies.
In conclusion, proteomics opens new horizons in cancer research. It has gained great importance because it targets proteins, which play more functional roles in cancer than genes.
Sources
Proteomics Approaches towards Early Detection and Diagnosis of Cancer
J Carcinogene Mutagene 2013, S14
2. Pothur R. Srinivas
Proteomics for Cancer Biomarker Discovery
Clinical Chemistry Aug 2002, 48 (8) 1160-1169;
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.